Teva Pharmaceuticals USA is recalling 7,081 bottles of Lansoprazole (Prevacid) Delayed-Release Orally Disintegrating Tablets, 15 mg, because the medication was found to be subpotent. This means the drug may not have the full strength required to effectively treat acid-related stomach conditions. The affected prescription medication was distributed nationwide in bottles containing 100 tablets (arranged in 10 blister cards). Consumers should contact their doctor or pharmacist to discuss alternative treatments, as this specific lot does not meet quality standards.
Because this medication is subpotent, it contains less active ingredient than specified, which can lead to ineffective treatment of conditions like acid reflux or stomach ulcers. While the risk of immediate harm is low, the failure to control stomach acid could lead to a return of symptoms or a worsening of the underlying condition.
Pharmaceutical product return and consultation.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.